Sumitomo Mitsui Trust Group Inc. Has $15.06 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sumitomo Mitsui Trust Group Inc. lowered its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 39.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,613,603 shares of the pharmacy operator’s stock after selling 1,069,544 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.19% of Walgreens Boots Alliance worth $15,055,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of WBA. Silver Oak Securities Incorporated bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $110,000. Centennial Wealth Advisory LLC grew its holdings in shares of Walgreens Boots Alliance by 44.6% during the fourth quarter. Centennial Wealth Advisory LLC now owns 24,750 shares of the pharmacy operator’s stock worth $231,000 after buying an additional 7,637 shares in the last quarter. Robertson Stephens Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 11.8% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 12,220 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 1,289 shares in the last quarter. Choreo LLC grew its holdings in shares of Walgreens Boots Alliance by 17.0% during the fourth quarter. Choreo LLC now owns 110,932 shares of the pharmacy operator’s stock worth $1,032,000 after buying an additional 16,103 shares in the last quarter. Finally, Money Concepts Capital Corp grew its holdings in shares of Walgreens Boots Alliance by 10.0% during the fourth quarter. Money Concepts Capital Corp now owns 64,396 shares of the pharmacy operator’s stock worth $601,000 after buying an additional 5,849 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Ratings Changes

WBA has been the subject of a number of research reports. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Stock Performance

WBA opened at $9.47 on Thursday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.55. The stock has a market cap of $8.18 billion, a price-to-earnings ratio of -0.92, a PEG ratio of 1.26 and a beta of 0.65. The business has a 50 day moving average of $10.25 and a 200-day moving average of $9.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the firm posted $0.66 EPS. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.